Jim Burke, M.D. is a neurologist who completed residency and a stroke fellowship at the University of Michigan. His undergraduate degree is from the University of Notre Dame and his medical degree from the Loyola University Stritch School of Medicine. He is interested in understanding how physicians use the complex information acquired from modern diagnostic tests and improving decisions to order such tests.
Page not found
This month's grand rounds features: Michael Jibson, MD, Psychiatry Department speaking about "Psychiatry, Law, and Society: Ethical and Legal Issues in Mental Health"
Please join us for a lively discussion of medical ethics. The Bioethics Grand Rounds is co-sponsored by the Center for Bioethics and Social Sciences in Medicine, the UMHS Adult and Pediatric Medical Ethics Committee, and the Program of Society and Medicine. This educational session is open to all faculty and staff and members of the public. CME credit is available.
To meet ACCME requirements for Faculty Planner disclosure and Presenter Disclosure to participants of CME activities at UM, please be advised that the following faculty planner(s)/co-planner(s) and presenter have no personal financial relationships relevant to the activity listed below:
- Andrew Shuman, MD
- Christian Vercler, MD
Carl Schneider, JD -- “Can Informed-Consent Laws Work? Evaluating Compelled Disclosure as a Method of Regulation”
Abstract: The law of informed consent is an example of a form of legal regulation called mandated disclosure. In such regulation, one party to a transaction is required to give the other party to the transaction information to use in making decisions about the parties’ relationship. There are hundreds of examples of such legal rules besides medical informed consent. This talk asks how well these rules have worked outside medicine. It concludes that there is little evidence that those rules ever work, explores some of the reasons for this surprising failure, and asks what the failure of mandated disclosure outside medicine tells us about the success of informed-consent laws in medicine.
Paul Lichter, MD
The Medical-Industrial Complex is alive and well and has been that way for decades. The Complex depends on strong cooperation from physicians. Not only do physicians help industry to develop drugs and devices, they then take part in selling them to their fellow physicians. The physician-as-drug-rep is driven by money and by the culture of reciprocity in our society. This talk will review the foundations of the Medical-Industrial Complex and the reasons why it is able to control a great deal of medical practice in our country. Physicians rarely if ever believe they are biased and Industry works hard to enforce that belief. Money provided by Industry to physicians in essence creates a contract, however subtle, whereby physicians will sell drugs and devices for Industry. We will discuss the ethical issues surrounding physician-industry relationships as part of the Medical-Industrial Complex.
Michigan Medicine has launched Victors Care, a concierge medical care model designed to deliver increased access, convenience and individually-tailored support within a primary care practice for patients who pay for membership. Like all concierge care programs, Victors Care raises ethical issues relating to justice, fairness, access, and consistency with the mission of Michigan Medicine. This Bioethics Grand Rounds will address the ethical issues of concierge care in a panel format with institutional leaders. The panel will address your questions directly. Questions will be solicited during the session, and can be submitted in advance via: https://umichumhs.qualtrics.com/jfe/form/SV_b4nJWM70ahHQtjD.
Marschall S. Runge, M.D., Ph.D., EVPMA and Dean
Reshma Jagsi, M.D., D.Phil, Director, Center for Bioethics and Social Sciences in Medicine
David J. Brown, M.D., Associate Vice President and Associate Dean for Health Equity and Inclusion
Andrew Shuman, M.D., F.A.C.S & Christian J. Vercler, M.D, M.A, F.A.C.S – Service Chiefs, Clinical Ethics Service, Center for Bioethics and Social Sciences in Medicine
The University of Michigan School of Public Health has received federal funding to launch an integrated, interdisciplinary fellowship program that will provide training in the ethical, legal, and social implications (ELSI) of genomic science.
Led by Scott Roberts, professor of health behavior and health education at Michigan Public Health, the ELSI Research Training Program is funded by a T32 training grant from the National Institutes of Health’s National Human Genome Research Institute and will launch in fall 2018. Raymond De Vries, Wendy Uhlmann, Brian Zikmund-Fisher, Jodyn Platt, Kayte Spector-Bagdady are among the faculty who will serve as faculty mentors.
More information can be found here.
Ryan Antiel, MD, MSME, Department of General Surgery, Biomedical Ethics Program, Mayo Clinic
Extreme prematurity is the leading cause of infant death and morbidity. The urgent need for a better way to support the extremely premature infant led to the development of an extrauterine system to better bridge the transition from fetal to postnatal life. The goal of this “artificial womb” is to maintain prenatal physiology in the extremely premature neonate to support normal development and reduce the complications associated with prematurity. In this presentation, we will discuss the development and applications of the artificial womb, as well as the limitations of this technology. We will focus on three current ethical challenges: ectogenesis, the boundary of viability, and the difference between physiological and clinical success.
"Transparency in Surgery"
The operating room shifted over the last century from a historically open "theatre" to a sequestered space, and the proceedings of surgery became a mystery to those outside the surgical profession. The more recent and increasing societal interest in transparency suggests professions such as surgery must develop new strategies to engender trust and inform the public and patients about what happens behind closed doors. Simultaneously, video and sensor technology has evolved to enable ubiquitous recording and analysis of surgical activities, creating a new source of data and the potential to reinstate a virtual surgical theatre. Such openness of a previously hidden space has implications for patients and surgical teams. This presentation will discuss the important ethical, technological, and regulatory considerations and challenges of a transition to greater transparency in surgery.